Home
University of Bergen
Christian Beisland's picture

Christian Beisland

Department of Clinical Medicine
  • E-mailChristian.Beisland@uib.no
  • Phone+47 55 97 29 02
  • Visitor Address
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2023). Ureteroscopy in Patients with Urinary Diversion: Outcomes and Lessons Learned from Two European Centres. European Urology Open Science. 85-90.
  • Show author(s) (2023). Ureteroscopy for Stone Disease in Extremely Elderly Patients (≥85 Years): Outcomes and Lessons Learned. Journal of endourology. 245-250.
  • Show author(s) (2023). Ureteroscopy during pregnancy: Outcomes and lessons learned over 4 decades at a tertiary center in Norway. Current urology. 7-12.
  • Show author(s) (2023). Ureteroscopy during pregnancy under local anesthesia and light sedation: Technique and video. Current urology. 219-220.
  • Show author(s) (2023). Paediatric Ureteroscopy (P-URS) reporting checklist: a new tool to aid studies report the essential items on paediatric ureteroscopy for stone disease. Urolithiasis. 6 pages.
  • Show author(s) (2023). Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence Groups. European Urology Open Science. 65-72.
  • Show author(s) (2023). Impact of prebiopsy MRI on prostate cancer staging: Results from the Norwegian Prostate Cancer Registry. BJU International.
  • Show author(s) (2023). Identifying possible biomarkers of lower urinary tract symptoms using metabolomics and partial least square regression. Metabolomics.
  • Show author(s) (2023). Editorial Comment: Thulium fibre laser versus Holmium:YAG for ureteroscopic lithotripsy: outcomes from a prospective randomised clinical trial. International Brazilian Journal of Urology. 267-268.
  • Show author(s) (2023). Device Failure and Adverse Events Related to Single-use and Reusable Flexible Ureteroscopes: Findings and New Insights From an 11-Year Analysis of the Manufacturer and User Facility Device Experience Database. Urology.
  • Show author(s) (2023). Complications and device failures associated with urolift: Findings from the MAUDE database. Urologia.
  • Show author(s) (2023). A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer. Cancer Immunology and Immunotherapy.
  • Show author(s) (2022). Ureteroscopy for stone disease in the paediatric population: lessons learned and outcomes in a Nordic setting. Therapeutic Advances in Urology. 1-9.
  • Show author(s) (2022). Thulium Fibre Laser versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. European Urology. 1-7.
  • Show author(s) (2022). Temperature profiles during ureteroscopy with thulium fiber laser and holmium:YAG laser: Findings from a pre-clinical study. Scandinavian Journal of Urology. 313-319.
  • Show author(s) (2022). Recurrence pattern in localized RCC: results from a European multicenter database (RECUR). Urologic Oncology. 494.e11-494.e17.
  • Show author(s) (2022). IPSS “bother question” score predicts health-related quality of life better than total IPSS score. World Journal of Urology. 765-772.
  • Show author(s) (2022). A multiomics disease progression signature of low-risk ccRCC. Scientific Reports. 1-15.
  • Show author(s) (2021). The levels of IL-6 and soluble IL-33R are increased in the renal vein during surgery for clear cell renal cell carcinoma. Cytokine. 1-10.
  • Show author(s) (2021). The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients. The journal of pathology. Clinical research. 253-270.
  • Show author(s) (2021). The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium. European Urology Oncology (EUO). 473-482.
  • Show author(s) (2021). Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy? BJU International. 386-394.
  • Show author(s) (2021). Rules and regulations for a pregnant endourologist: the European perspective. World Journal of Urology. 8 pages.
  • Show author(s) (2021). Prevalence, disease-free, and overall survival of contemporary patients with renal cell carcinoma eligible for adjuvant checkpoint inhibitor trials. Clinical Genitourinary Cancer. 1-8.
  • Show author(s) (2021). Preoperative predictors of pathological tumour stage and prognosis may be used when selecting candidates for intensified treatment in upper tract urothelial carcinoma. Scandinavian Journal of Urology. 100-107.
  • Show author(s) (2021). Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma. World Journal of Urology. 3823-3831.
  • Show author(s) (2021). Higher than expected and significantly increasing incidence of upper tract urothelial carcinoma. A population based study. World Journal of Urology. 1-7.
  • Show author(s) (2021). AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease. Cancer Cell International. 12 pages.
  • Show author(s) (2020). The biological context of c-reactive protein as a prognostic marker in renal cell carcinoma: Studies on the acute phase cytokine profile. Cancers. 1-18.
  • Show author(s) (2020). Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC). Cancer Immunology and Immunotherapy. 1-12.
  • Show author(s) (2020). Personality and educational level determine self-reported health-related quality-of-life and distress in patients with renal tumors awaiting radical surgery. Scandinavian Journal of Urology. 304-312.
  • Show author(s) (2020). Non-metastatic prostate cancer: rationale for conservative treatment and impact on disease-related morbidity and mortality in the elderly. Scandinavian Journal of Urology. 105-109.
  • Show author(s) (2020). Magnetic resonance radiomics for prediction of extraprostatic extension in non-favorable intermediate- and high-risk prostate cancer patients. Acta Radiologica. 1570-1579.
  • Show author(s) (2020). Assessing extraprostatic extension by mpMRI of the prostate: Mehralivand’s EPE grade or EPE Likert score? Radiology: Imaging Cancer. 1-10.
  • Show author(s) (2019). Tumour architecture, grade and location remain predictors of non-organ-confined upper tract urothelial carcinoma at time of radical nephroureterectomy: results from a multicenter Norwegian external validation study. World Journal of Urology. 717-723.
  • Show author(s) (2019). Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms. American Journal of Physiology - Renal Physiology (AJP).
  • Show author(s) (2019). Increased use of cross-sectional imaging for follow-up does not improve post-recurrence survival of surgically treated initially localized R.C.C.: results from a European multicenter database (R.E.C.U.R.). Scandinavian Journal of Urology. 14-20.
  • Show author(s) (2019). FOXC2 expression and epithelial–mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer. The journal of pathology. Clinical research. 272-286.
  • Show author(s) (2019). Elevated plasma interleukin 6 predicts poor response in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. Cancer Treatment and Research Communications. 1-5.
  • Show author(s) (2018). Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors: a questionnaire survey in the Nordic countries (The NORENCA-2 study). Open Access Journal of Urology. 181-187.
  • Show author(s) (2018). Tumour cell expression of interleukin 6 receptor a is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. The journal of pathology. Clinical research. 114-123.
  • Show author(s) (2018). Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma. New England Journal of Medicine. 417-427.
  • Show author(s) (2018). Novel protein signatures suggest progression to muscular invasiveness in bladder cancer. PLOS ONE. 1-15.
  • Show author(s) (2018). National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival. European Urology Oncology (EUO). 252-261.
  • Show author(s) (2018). Long-term outcomes of follow-up for initially localised clear cell renal cell carcinoma: RECUR database analysis. European Urology Focus. 857-866.
  • Show author(s) (2018). Intensive imaging-based follow-up of surgically treated localised renal cell carcinoma does not improve post-recurrence survival: Results from a European multicentre database (RECUR). European Urology. 1-4.
  • Show author(s) (2018). Intensity-based volumetric registration of magnetic resonance images and whole-mount sections of the prostate. Computerized Medical Imaging and Graphics. 24-30.
  • Show author(s) (2018). Fine needle aspirates of kidneys: A promising tool for RNA sequencing in native and transplanted kidneys. BMC Nephrology. 1-9.
  • Show author(s) (2018). External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. World Journal of Urology. 1-8.
  • Show author(s) (2018). Expanding the utilization of formalin-fixed, paraffin-embedded archives: Feasibility of miR-Seq for disease exploration and biomarker development from biopsies with clear cell renal cell Carcinoma. International Journal of Molecular Sciences. 1-18.
  • Show author(s) (2018). Dictionary-based through-plane interpolation of prostate cancer T2-weighted MR images. Signal Processing - Algorithms, Architectures, Arrangements, and Applications Conference Proceedings, SPA. 168-173.
  • Show author(s) (2018). CRF-Based clustering of pharmacokinetic curves from dynamic contrast-enhanced MR images. Signal Processing - Algorithms, Architectures, Arrangements, and Applications Conference Proceedings, SPA. 174-179.
  • Show author(s) (2017). Use of diagnostic biopsies in kidney tumors. Scandinavian Journal of Urology. 185-192.
  • Show author(s) (2017). Rule-based data-driven approach for computer aided diagnosis of the peripheral zone prostate cancer from multiparametric MRI: Proof of concept. Signal Processing - Algorithms, Architectures, Arrangements, and Applications Conference Proceedings, SPA. 90-95.
  • Show author(s) (2017). Reconstruction of high-resolution T2W MR images of the prostate using maximum a posteriori approach and Markov random field regularization. Signal Processing - Algorithms, Architectures, Arrangements, and Applications Conference Proceedings, SPA. 96-99.
  • Show author(s) (2017). Real-life use of diagnostic biopsies before treatment of kidney cancer: results from a Norwegian population-based study. Scandinavian Journal of Urology. 38-44.
  • Show author(s) (2017). Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. BMC Urology. 1-11.
  • Show author(s) (2017). Overall Survival in Renal Cell Carcinoma after Introduction of Targeted Therapies: A Norwegian Population-Based Study. OncoTargets and Therapy. 371-385.
  • Show author(s) (2017). Optimising preoperative risk stratification tools for prostate cancer using mpMRI. European Radiology. 1016-1026.
  • Show author(s) (2017). Incidental detection of renal cell carcinoma. Scandinavian Journal of Urology. 178-184.
  • Show author(s) (2017). Contemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study). Scandinavian Journal of Urology. 360-366.
  • Show author(s) (2017). Clear cell renal cell carcinoma is linked to epithelial-to-mesenchymal transition and to fibrosis. Physiological Reports. 1-18.
  • Show author(s) (2016). Trends in stage-specific incidence of prostate cancer in Norway, 1980–2010: a population-based study. BJU International. 547-555.
  • Show author(s) (2016). Transcriptome sequencing (RNAseq) enables utilization of formalin-fixed, paraffin-embedded biopsies with clear cell renal cell carcinoma for exploration of disease biology and biomarker development. PLOS ONE.
  • Show author(s) (2016). RNA extraction for RNA sequencing of archival renal tissues. Scandinavian Journal of Clinical and Laboratory Investigation. 426-434.
  • Show author(s) (2016). Postoperative 30-day mortality rates for kidney cancer are dependent on hospital surgical volume: results from a Norwegian population-based study. European Urology Focus. 300-307.
  • Show author(s) (2016). Nephron Sparing Surgery Associated with Better Survival Than Radical Nephrectomy in Patients Treated for Unforeseen Benign Renal Tumors. Urology. 117-123.
  • Show author(s) (2016). Grading of urothelial carcinoma of the upper urinary tract according to the World Health Organization/International Society of Urological Pathology classification from 2004 is a valuable tool when considering whether a patient is suitable for endoscopic treatment. Scandinavian Journal of Urology. 298-304.
  • Show author(s) (2016). Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients. Acta Oncologica. 349-356.
  • Show author(s) (2016). Development and confirmation of potential gene classifiers of human clear cell renal cell carcinoma using next-generation RNA sequencing. Scandinavian Journal of Urology. 452-462.
  • Show author(s) (2016). A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use. World Journal of Urology. 1087-1099.
  • Show author(s) (2016). A positive Real-Time Elastography (RTE) combined with a Prostate Cancer Gene 3 (PCA3) score above 35 convey a high probability of intermediate- or high-risk prostate cancer in patient admitted for primary biopsy. BMC Urology. 1-8.
  • Show author(s) (2015). Prostate cancer antigen-3 (PCA3) and PCA3-based nomograms in the diagnosis of prostate cancer: an external validation of Hansen's nomogram on a Norwegian cohort. Scandinavian Journal of Urology. 8-15.
  • Show author(s) (2015). Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma. Scandinavian Journal of Urology. 388-394.
  • Show author(s) (2015). Health-related quality of life, personality and choice of coping are related in renal cell carcinoma patients. Scandinavian Journal of Urology. 282-289.
  • Show author(s) (2015). Contemporary external validation of the Leibovich model for prediction of progression after radical surgery for clear cell renal cell carcinoma. Scandinavian Journal of Urology. 205-210.
  • Show author(s) (2015). 1.5-T multiparametric MRI using PI-RADS: a region by region analysis to localize the index-tumor of prostate cancer in patients undergoing prostatectomy. Acta Radiologica. 500-511.
  • Show author(s) (2014). Langtidsoverlevelse etter behandling av overgangsepitelkarsinom i ureter og nyrebekken. Kirurgen. 113-116.
  • Show author(s) (2014). Health-related quality of life in long-term survivors after renal cancer treatment. Scandinavian Journal of Urology and Nephrology. 52-64.
  • Show author(s) (2014). A positive real-time elastography is an independent marker for detection of high-risk prostate cancers in the primary biopsy setting. BJU International. E90-E97.
  • Show author(s) (2013). Incidentally detected renal cell carcinomas are highly associated with comorbidity and mortality unrelated to renal cell carcinoma. Scandinavian Journal of Urology and Nephrology. 462-471.
  • Show author(s) (2013). Does a surgeon’s annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study. Scandinavian Journal of Urology and Nephrology. 92-100.
  • Show author(s) (2012). Ureterskadar og handsaming av desse. Kirurgen. 217-219.
  • Show author(s) (2012). Testikkeltorsjoner behandlet ved Haukeland universitetssjukehus i årene 2000-2008. Kirurgen. 212-215.
  • Show author(s) (2012). Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma. Scandinavian Journal of Urology and Nephrology. 348-357.
  • Show author(s) (2012). Combination of real-time elastography and urine prostate cancer gene 3 (PCA3) detects more than 97 % of significant prostate cancers. Scandinavian Journal of Urology and Nephrology. 211-216.
  • Show author(s) (2009). Observation should be considered as an alternative in management of renal masses in lder and comorbid patients. European Urology. 1419-1429.
  • Show author(s) (2006). Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study. BJU International. 698-702.
  • Show author(s) (2004). Vitiligo--an autoimmune side-effect of intravesical bacillus Calmette-Guerin instillation? Scandinavian Journal of Urology and Nephrology. 182-183.
  • Show author(s) (2004). Presumed radically treated renal cell carcinoma--recurrence of the disease and prognostic factors for subsequent survival. Scandinavian Journal of Urology and Nephrology. 299-305.
  • Show author(s) (2004). Natural and clinical course of renal cell carcinoma--better prospect for the patients. Scandinavian Journal of Surgery. 97-101.
  • Show author(s) (2002). Nyrekreft - en retrospektiv undersøkelse av 368 pasienter. Tidsskrift for Den norske legeforening. 2431-2435.
Lecture
  • Show author(s) (2015). Post ASCO GU 2015 - Nyre/ Blære; Hva er nytt!
Academic lecture
  • Show author(s) (2019). Personality and choice of coping are important for self-reported health-related quality of life in patients with renal tumors prior to radical surgery.
  • Show author(s) (2019). Level of distress is closely related to personality and choice of coping in patients with renal tumors prior to radical surgery.
  • Show author(s) (2019). Cytoreductive and palliative renal surgery.
  • Show author(s) (2013). Psykometrisk validering av et diagnosespesifikt livskvalitets- skjema (HRQoL,) ment brukt sammen med det generelle EORTC livskvalitests- skjemaet (QLQ) på nyrekreft-pasienter.
  • Show author(s) (2013). Psychometric validation of a disease-specific Health Related Quality of Life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization of Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in Renal Cell Carcinoma patients.
  • Show author(s) (2012). Radiologisk vs. patologisk størrelse av nyrecellecarcinomer i stadium I og II - betydning for stadiumspesifikk overlevelse.
  • Show author(s) (2012). Radikale prostatektomier ved Haukeland universitetssjukehus 2010-2012.
  • Show author(s) (2012). Pyeloplastikk på barn - erfaringer fra Haukeland universitetssjukehus 2001-2011.
  • Show author(s) (2012). Oppstart med behandling av postprostatektomi inkontinens (PPI) ved Haukeland universitetssjukehus.
  • Show author(s) (2012). Læringskurven for RALP ved Haukeland universitetssjukehus 2010-2012.
  • Show author(s) (2012). Lymfekjerteltoilette (PLND) ved radikale prostatektomier ved Haukeland universitetssjukehus 2010-2012.
  • Show author(s) (2012). Evaluering av oppfølgningsprogrammet for nyrekreft (RCC)ved Haukeland universitetssjukehus.
  • Show author(s) (2010). Real time elastografi ved cancer prostatae.
  • Show author(s) (2010). Preliminære resultater av PCA3 måling i urin hos pasienter med cancer prostatae.
  • Show author(s) (2010). Er preoperativ MR-prostata nyttig for å avklare korrekt T-stadium forut for kirurgi?
  • Show author(s) (2010). Er MR-prostata nyttig for å avklare videre oppfølgningsbehov hos pasienter med 2 eller flere negative biopsiserier?
  • Show author(s) (2002). Overlevelse etter metastasering fra nyrecelle carcinom (RCC) - hvilke prognostiske faktorer har betydning?
  • Show author(s) (2002). Innføring av laparoskopisk PLND ved cancer prostatae som standard operasjonsmetode - gir det noen gevinst?
  • Show author(s) (2002). Genital selvmutilering (GSM) - ren skjær galskap eller .. ?
  • Show author(s) (1991). Ileal Conduit ad modum Bricker. Complications and Quality of Life. .
Editorial
  • Show author(s) (2020). Cytoreductive nephrectomy in primary metastatic clear cell renal cell carcinoma. Scandinavian Journal of Urology.
Reader opinion piece
  • Show author(s) (2013). Untitled. American Journal of Clinical Oncology. 423-423.
Letter to the editor
  • Show author(s) (2023). Traffic light system for simplified decision-making for stent insertion and removal at the time of ureteroscopy. Urolithiasis.
  • Show author(s) (2023). Adult Ureteroscopy (A-URS) Checklist: A New Tool To Standardise Reporting in Endourology. European Urology Open Science. 1-5.
  • Show author(s) (2022). Ureteroscopy in pregnancy can be a preferred option and not just a last resort. World Journal of Urology.
  • Show author(s) (2022). Reply to Jinze Li, Yin Huang, Dehong Cao, and Qiang Wei's Letter to the Editor re: Øyvind Ulvik, Mathias Sørstrand Æsøy, Patrick Juliebø-Jones, Peder Gjengstø, Christian Beisland. Thulium Fibre Laser Versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Eur Urol. 2022;82:73–79. European Urology. e72.
  • Show author(s) (2022). Reply to Hyung Joon Kim and Khurshid R. Ghani's Letter to the Editor re: Øyvind Ulvik, Mathias Sørstrand Æsøy, Patrick Juliebø-Jones, Peder Gjengstø, Christian Beisland. Thulium Fibre Laser Versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Eur Urol. 2022;82:73–9. European Urology. e41-e42.
  • Show author(s) (2022). Reply to Frederic Panthier, Alba Sierra, and Olivier Traxer's Letter to the Editor re: Øyvind Ulvik, Mathias Sørstrand Æsøy, Patrick Juliebø-Jones, Peder Gjengstø, Christian Beisland. Thulium Fibre Laser Versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Eur Urol. 2022;82:73–9. European Urology. e37-e38.
  • Show author(s) (2022). Reply to Alan J. Yaghoubian, Jonathan A. Khusid, and Mantu Gupta's Letter to the Editor re: Øyvind Ulvik, Mathias Sørstrand Æsøy, Patrick Juliebø-Jones, Peder Gjengstø, Christian Beisland. Thulium Fibre Laser Versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Eur Urol. 2022;82:73–9. European Urology. e45-e46.
  • Show author(s) (2013). Letter to the Editor. American Journal of Clinical Oncology. 423-423.
Doctoral dissertation
  • Show author(s) (2019). Late-Stage Prostate Cancer and Prostate Cancer Mortality. A Population-Based Study.
  • Show author(s) (2018). A population based study on Kidney Cancer in Norway (2008 - 2013).
  • Show author(s) (2006). Epidemiological and Clinical Aspects in Diagnosis and Treatment of Renal Cell Carcinoma.
Abstract
  • Show author(s) (2022). Development of an EORTC Quality of Life Module for Renal Cell Cancer Patients: Phase I. European psychiatry. S756-S756.
  • Show author(s) (2016). Perioperative 30-day mortality rates are dependent on hospital surgical volume – results from a Norwegian population based study on surgical treatment for renal cell carcinoma. European Urology. Supplement. e520.
  • Show author(s) (2016). Changes in surgical treatment of modalities for renal cell carcinoma ≤ 7 cm – a Norwegian population based study 2008-2013. European Urology. Supplement. e1089.
  • Show author(s) (2013). Survival after treatment for urothelial carcinoma in the upper urinary tract. Results of the final analysis-25 years postsurgery. Scandinavian Journal of Urology and Nephrology. 33-33.
  • Show author(s) (2013). Serum VEGF in patients with renal tumours and low contrast enhancement on ct can be used to predict survival and recurrence. Scandinavian Journal of Urology and Nephrology. 32-33.
  • Show author(s) (2013). Health related quality of life (HRQoL), personality and choice of coping is associated in renal cell carcinoma patients. Scandinavian Journal of Urology and Nephrology. 33-34.
Poster
  • Show author(s) (2022). Quality assessment of transurethral resection of bladder tumours (TURB) and association between bladder lesion appearances and malignancy: Findings from a Norwegian tertiary centre.
  • Show author(s) (2022). Cancer patients ≥80 years of age admitted for surgical treatment – Baseline characteristics from the elderly somatic cancer patient study (ELDSOCA).
  • Show author(s) (2021). Development of an EORTC Quality of Life Module for Renal Cell Cancer Patients: Phase I.
  • Show author(s) (2019). Helse og livskvalitet hos kognitivt intakte elektive kreftpasienter over 80 år .
  • Show author(s) (2018). Fine needle aspirates of kidneys are usable for RNA sequencing like regular core biopsies.
  • Show author(s) (2018). Expanding the utilization of formalin-fixed, paraffin-embedded archives: Feasability of miRNA-sequencing for disease exploration and biomarker development from biopsies with clear cell renal cell carcinoma.
  • Show author(s) (2016). Detection and Validation of Epithelial-to-Mesenchymal Transition(EMT) with Increased Expression of Axl and MMP-14 in Renal Cell Carcinoma.
  • Show author(s) (2015). C-reactive protein as a predictive marker of response to sunitinib treatment in metastatic clear cell renal cell carcinoma.
  • Show author(s) (2014). Registration of multiparametric MRI and whole-mount sections of the prostate.
  • Show author(s) (2014). Registration of multiparametric MRI and whole-Mount sections prostate.
  • Show author(s) (2013). Health related quality of life (HRQoL) personality and choice of coping is associated in renal cell carcinoma patinets.
Errata
  • Show author(s) (2023). Correction to: Current status of patient-reported outcome measures and other subjective assessment grading tools in bladder pain syndrome (International Urogynecology Journal, (2023), 10.1007/s00192-023-05551-z). International Urogynecology Journal.
  • Show author(s) (2021). Corrigendum to “The levels of IL-6 and soluble IL-33R are increased in the renal vein during surgery for clear cell renal cell carcinoma” [Cytokine 144 (2021) 155586](S1043466621001691)(10.1016/j.cyto.2021.155586). Cytokine.
Academic literature review
  • Show author(s) (2023). Paediatric kidney stone surgery: state-of-the-art review. Therapeutic Advances in Urology.
  • Show author(s) (2023). Outcomes Associated with the Endourological Management of Stent Encrustation: Findings from a Literature Review on Behalf of the EAU YAU Urolithiasis Group. Current Urology Reports. 187-199.
  • Show author(s) (2022). Management of kidney stone disease in pregnancy: A practical and evidence-based approach. Current Urology Reports. 8 pages.
  • Show author(s) (2022). Management of Bladder Pain Syndrome (BPS): A Practical Guide. Advances in Urology. 1-9.
  • Show author(s) (2022). Current status of nomograms and scoring systems in paediatric endourology: A systematic review of literature. Journal of Pediatric Urology. 13 pages.
  • Show author(s) (2022). Advances in Ureteroscopy: New technologies and current innovations in the era of Tailored Endourological Stone Treatment (TEST). Journal of Clinical Urology (JCU). 1-9.
  • Show author(s) (2021). Endourological management of encrusted ureteral stents: an up-to-date guide and treatment algorithm on behalf of the European Association of Urology Young Academic Urology Urolithiasis Group. Central European Journal of Urology. 571-578.
  • Show author(s) (2021). Current status of thulium fibre laser lithotripsy: an up-to-date review. BJU International. 531-538.
  • Show author(s) (2021). Current Status of Intravesical Therapies for Bladder Pain Syndrome (BPS): A Narrative Review of Emerging Evidence. Urology. e48-e57.
  • Show author(s) (2014). Traumatiske skader i nyra – ei orientering for dei utan spesialistkompetanse. Kirurgen. 119-123.
  • Show author(s) (2008). Radikal behandling av Cancer Renis – En oversikt for kirurger. Kirurgen. 12-15.

More information in national current research information system (CRIStin)